Tempest Therapeutics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
MRKMerck & Co., Inc. 1.97%81.060.7%$1593.97m
JNJJohnson & Johnson -0.06%163.780.7%$1029.66m
PFEPfizer Inc. 1.68%42.800.9%$939.71m
ABBVAbbVie, Inc. 0.85%108.361.9%$679.27m
BMYBristol-Myers Squibb Co. 0.87%58.091.0%$658.95m
LLYEli Lilly & Co. 0.62%243.821.1%$610.86m
AZNAstraZeneca Plc 0.74%60.621.0%$366.78m
NVSNovartis AG 1.55%84.440.2%$176.75m
GSKGlaxoSmithKline Plc 0.78%39.480.2%$162.05m
RGENRepligen Corp. 1.95%267.776.8%$117.87m
AVIRAtea Pharmaceuticals, Inc. -4.49%13.200.3%$116.41m
VTRSViatris, Inc. 3.10%13.990.0%$92.80m
NVONovo Nordisk A/S -0.13%104.520.1%$91.58m
EDSAEdesa Biotech, Inc. -1.03%8.140.0%$73.37m
SNYSanofi 2.25%49.140.2%$64.87m

Company Profile

Tempest Therapeutics, Inc.is a clinical-stage biotechnology company. It develops small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. The company is headquartered in South San Francisco, CA.